These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6491977)

  • 1. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and chloramphenicol in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):80-4. PubMed ID: 6491977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin enantiomers and metronidazole in rats.
    Yacobi A; Lai CM; Levy G
    J Pharmacol Exp Ther; 1984 Oct; 231(1):72-9. PubMed ID: 6491976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rutin on warfarin anticoagulation and pharmacokinetics of warfarin enantiomers in rats.
    Chan E; Hegde A; Chen X
    J Pharm Pharmacol; 2009 Apr; 61(4):451-8. PubMed ID: 19298691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent stereopharmacokinetics of 5,6-dihydro-4H-4(isobutylamino)thieno(2,3-B)thiopyran-2-sulfonamide-7,7 -dioxide , a potent carbonic anhydrase inhibitor, in rats.
    Lin JH; Ulm EH; Los LE
    Drug Metab Dispos; 1991; 19(1):233-8. PubMed ID: 1673405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic interaction between theophylline and chloramphenicol in rats.
    Busby M; Lesko LJ
    Drug Metab Dispos; 1987; 15(2):204-6. PubMed ID: 2882979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselective aspects in the pharmacokinetics and pharmacodynamics of acenocoumarol and its amino and acetamido derivatives in the rat.
    Thijssen HH; Baars LG; Drittij-Reijnders MJ
    Drug Metab Dispos; 1985; 13(5):593-7. PubMed ID: 2865109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance.
    Takahashi H; Kashima T; Kimura S; Murata N; Takaba T; Iwade K; Abe T; Tainaka H; Yasumori T; Echizen aH
    Drug Metab Dispos; 1999 Oct; 27(10):1179-86. PubMed ID: 10497145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin.
    Martini A; Jähnchen E
    J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kiiv, an in vivo parameter for predicting the magnitude of a drug interaction arising from competitive enzyme inhibition.
    Neal JM; Kunze KL; Levy RH; O'Reilly RA; Trager WF
    Drug Metab Dispos; 2003 Aug; 31(8):1043-8. PubMed ID: 12867493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clofibrate displaces warfarin from plasma proteins in man: an example of a pure displacement interaction.
    Bjornsson TD; Meffin PJ; Swezey S; Blaschke TF
    J Pharmacol Exp Ther; 1979 Sep; 210(3):316-21. PubMed ID: 480183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions of amitriptyline and nortriptyline with warfarin in the rat.
    Loomis CW; Racz WJ
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):41-58. PubMed ID: 7433768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children.
    Takahashi H; Ishikawa S; Nomoto S; Nishigaki Y; Ando F; Kashima T; Kimura S; Kanamori M; Echizen H
    Clin Pharmacol Ther; 2000 Nov; 68(5):541-55. PubMed ID: 11103757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misleading results in studying pharmacodynamic interaction with oral anticoagulant.
    de Feo G; Del Vecchio A; Orticelli G; Valeri P; Mazzanti G; Lisciani R; Noli G
    Boll Chim Farm; 1991 Mar; 130(3):94-6. PubMed ID: 1892612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereoselective differences in propranolol disposition in female Sprague-Dawley and Dark Agouti rats.
    Guttendorf RJ; Kostenbauder HB; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):251-6. PubMed ID: 1673410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misleading results in studying pharmacodynamic interaction with oral anticoagulants.
    de Feo G; Lisciani R; Del Vecchio A; Orticelli G; Valeri P; Noli G; Mazzanti G
    Boll Chim Farm; 1990 Apr; 129(4):166-8. PubMed ID: 2245005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo effect of 5- and 8-methoxypsoralens and cimetidine on R,S-warfarin metabolism in rat.
    Szutowski MM; Łukasik M; Wawer ZT; Chrobak K; Michalska M; Borzecka K; Brzeziński J
    J Appl Toxicol; 2002; 22(5):327-32. PubMed ID: 12355562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the interaction of 3S-hydroxy-10,11-dihydroquinidine on the pharmacokinetics and pharmacodynamics of warfarin.
    Trenk D; Möhrke W; Warth L; Jähnchen E
    Arzneimittelforschung; 1993 Aug; 43(8):836-41. PubMed ID: 8216438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the intestinal microflora on the elimination of warfarin in the rat.
    Remmel RP; Pohl LR; Elmer GW
    Drug Metab Dispos; 1981; 9(5):410-4. PubMed ID: 6117438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicokinetics of a single intravenous dose of rac-propranolol versus optically pure propranolol in the rat.
    Bode W; Toet AE; Stolker AA; van Ginkel LA; Groen K; Wemer J; de Wildt DJ
    Chirality; 1995; 7(8):626-31. PubMed ID: 8593256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.